“It really did suggest that in humans, these drugs, mTOR inhibitors, can improve something that becomes impaired with older adults,” said Adam Konopka, an assistant professor of geriatrics and gerontology at the University of Wisconsin, who was not involved in the research.
Office of Strategic Communication